CAPTRUST Financial Advisors
NVCR icon

CAPTRUST Financial Advisors’s NovoCure NVCR Stock Holding History

CAPTRUST Financial Advisors’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$479K Buy
31,635
+13,761
+77% +$208K ﹤0.01% 2206
2026
Q1 		$195K Buy
17,874
+7,228
+68% +$90.3K ﹤0.01% 2693
2025
Q4 		$138K Buy
+10,646
New +$137K ﹤0.01% 2580
2022
Q3 		– Sell
-1,239
Closed -$86K – 3353
2022
Q2 		$86K Buy
1,239
+360
+41% +$27.1K ﹤0.01% 2324
2022
Q1 		$73K Buy
879
+126
+17% +$9.28K ﹤0.01% 2506
2021
Q4 		$57K Sell
753
-10
-1% -$1K ﹤0.01% 2570
2021
Q3 		$89K Sell
763
-442
-37% -$66.8K ﹤0.01% 2163
2021
Q2 		$267K Buy
1,205
+851
+240% +$166K ﹤0.01% 1337
2021
Q1 		$47K Buy
354
+269
+316% +$42.6K ﹤0.01% 2463
2020
Q4 		$15K Hold
85
– – ﹤0.01% 2396
2020
Q3 		$10K Sell
85
-143
-63% -$11.4K ﹤0.01% 2281
2020
Q2 		$14K Buy
+228
New +$15K ﹤0.01% 2069
2019
Q4 		– Sell
-516
Closed -$39K – 1521
2019
Q3 		$39K Buy
516
+150
+41% +$12K ﹤0.01% 1074
2019
Q2 		$23K Buy
+366
New +$18.5K ﹤0.01% 1243

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

CAPTRUST Financial Advisors's NVCR Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its NovoCure (NVCR) stake by 77% in Q2 2026, buying an estimated $208K and bringing the position to 31,635 shares worth $479K. The position accounts for ﹤0.01% of the portfolio, ranked #2206.

CAPTRUST Financial Advisors first reported a position in NVCR in Q2 2019 and has held it in 14 quarters since. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • CAPTRUST Financial Advisors held 31,635 shares of NovoCure worth $479K as of Q2 2026.
  • CAPTRUST Financial Advisors bought 13,761 NovoCure shares in Q2 2026, an estimated $208K.
  • NovoCure made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2206 holding.
  • CAPTRUST Financial Advisors first reported a position in NovoCure in Q2 2019 and has held it in 14 quarters since.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.